This is where visual search comes in. With a smartphone and deep learning technologies offered by companies such as Clarifai, Google, and Fashwell, customers can take pictures of the products they're searching for and then e-commerce sites interpret the images and make product recommendations. According to a June 2017 eMarketer report, 52% of consumers have trouble finding the exact products they're seeking online, but 68% are willing to consider alternatives if their desired product cannot be found. So AI can also help consumers discover new brands.
Register for this webinar to learn how to manage and support an employee advocacy program from planning through success. On top of making ads for marketers, agencies have long created products of their own, from Eos lip balm by Anomaly to the HurryCane walking stick from Minneapolis direct-response shop Marketing Architects. Now agencies are pouring resources into developing a very different kind of intellectual property: marketing technology. As brands spend more money to reach the right consumers with the right messages in digital media, agencies are looking to go after those dollars by creating the tech to help, such as tools to gauge consumer sentiment or optimize campaigns while they're still running. For marketers that buy in, shops often charge a monthly, subscription-like service or tech fee, a departure from the common per-head compensation model that agencies use to charge clients for traditional services.
Fujifilm Holdings Corp.'s new president, Kenji Sukeno, aims to make its pharmaceutical operations profitable and said the company will consider acquisitions to bolster growth in sectors where it has an existing presence. The company is targeting 20 percent operating margins in its drug operations and aims to make the business profitable in the fiscal year starting April 2018, Sukeno said in an interview in Tokyo. Last March, Fujifilm agreed to pay 307 million for U.S.-based Cellular Dynamics International Inc., a producer of iPS cells, a type of stem cell capable of morphing into any body part. The hope is that its regenerative medicine units could someday create cells to help damaged organs like the liver or pancreas grow again. In 2008, Fujifilm acquired drugmaker Toyama Chemical Co., maker of an anti-viral drug that was used by some Ebola patients in 2014.
This year, CES was laser focused on applications, highlighting intelligent voice interfaces in the vein of Amazon's Echo/Alexa. We heard less about IoT and more about intelligent and connected products. More interestingly, the devices in the internet of things are getting smarter. While pretty much every IoT use case thus far has employed the cloud to do the heavy lifting as far as compute-intensive analytics and machine learning capabilities are concerned, that paradigm has started to shift. The company where I serve as CTO is working on our own IoT platform, and develops these sorts of engines along with other IoT technologies.